Woods Black Norbury syndrome

From WikiMD's WELLNESSPEDIA

Other Names: Neonatal death immune deficiency; X-linked immunoneurological disorder

X-linked immunoneurologic disorder is characterized by immune deficiency and neurological disorders in females, and by neonatal death in males.

Epidemiology[edit]

The syndrome has been described in only one family with nine affected individuals (five males and four females) spanning two generations.

Cause[edit]

The gene locus has been mapped to Xq26-qter.

Inheritance[edit]

X-linked dominant inheritance

The condition is thought to be transmitted in an X-linked dominant manner.

Signs and symptoms[edit]

Symptomatic females present slowly progressive proximal muscle weakness, leg hyperreflexia, pes cavus, increased muscle tone in the legs, poor bladder function, static reduced night vision, and frequent sinopulmonary infections associated with IgG2 deficiency. Males present with low birth weight and severe hypotonia that leads to death in the neonatal period.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 30%-79% of people have these symptoms

  • Decreased circulating IgG2 level
  • Functional abnormality of the bladder
  • Hemiplegia/hemiparesis(Paralysis or weakness of one side of body)
  • Hyperreflexia(Increased reflexes)
  • Hypertonia
  • Nyctalopia(Night blindness)
  • Nystagmus(Involuntary, rapid, rhythmic eye movements)
  • Recurrent respiratory infections(Frequent respiratory infections)

5%-29% of people have these symptoms

  • Abnormal pleura morphology
  • Cataract(Clouding of the lens of the eye)
  • Myopathy(Muscle tissue disease)

Diagnosis[edit]

The syndrome should be considered in the differential diagnosis of hereditary spastic paraplegia in females and of other causes of severe neonatal hypotonia in males.

Treatment[edit]

NIH genetic and rare disease info[edit]

Woods Black Norbury syndrome is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.